Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management issues in herpes zoster

D E Dwyer1

  • 1Centre for Infectious Diseases and Microbiology, Westmead Hospital, New South Wales.

Australian Family Physician
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples.

Journal of clinical microbiology·2021
Same author

Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low.

Pathology·2020
Same author

Response.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2020
Same author

Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2020
Same author

Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2015
Same author

Virological diagnosis of Ebolavirus infection.

Pathology·2015
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Herpes zoster, or shingles, causes significant acute and chronic pain. Early antiviral treatment effectively manages shingles pain and postherpetic neuralgia, with newer medications offering improved convenience and effectiveness.

Area of Science:

  • Virology
  • Immunology
  • Dermatology

Background:

  • Herpes zoster (shingles) is a prevalent viral infection characterized by severe acute and chronic pain.
  • Pain management is a critical aspect of treating herpes zoster and its sequelae.
  • Postherpetic neuralgia (PHN) and zoster-associated pain (ZAP) represent significant challenges in patient care.

Purpose of the Study:

  • To evaluate the efficacy of antiviral agents in managing herpes zoster and associated pain.
  • To review the benefits of early intervention with antiviral therapy.
  • To highlight advancements in antiviral treatments for shingles and PHN.

Main Methods:

  • Systematic review of clinical trials and observational studies.
  • Analysis of treatment outcomes for antiviral agents initiated within 72 hours of rash onset.

Related Experiment Videos

  • Comparison of efficacy and convenience of newer antiviral medications.

    • Main Results:

    • Antiviral agents initiated within 72 hours of rash onset demonstrate significant effectiveness in treating acute herpes zoster.
    • Early antiviral treatment reduces the incidence and severity of postherpetic neuralgia and zoster-associated pain.
    • Newer antiviral agents provide enhanced efficacy and improved dosage convenience compared to older treatments.

    Conclusions:

    • Timely administration of antiviral therapy is crucial for managing herpes zoster and its painful complications.
    • Antiviral medications are effective in both the acute phase of shingles and the management of chronic pain conditions like PHN.
    • Advancements in antiviral drug development offer improved therapeutic options for patients suffering from herpes zoster and related pain.